S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire
S&P 500   4,330.00
DOW   34,070.42
QQQ   357.86
3 Compelling Reasons to Start Buying Undervalued Amazon
The Strategic Gold Play You Haven't Heard About (Ad)
Stock market today: World shares are mixed, Chinese markets surge, after latest retreat on Wall St
Analysts Recommend These Mining Stocks Before Metal Prices Rally
The Strategic Gold Play You Haven't Heard About (Ad)
FedEx, Greenbrier rise; Cisco Systems, KB Home fall, Thursday, 9/21/2023
Turkey’s central bank hikes interest rates again in further shift in economic policies
The Strategic Gold Play You Haven't Heard About (Ad)
The average long-term US mortgage rate edged up to 7.19% this week, slightly below its 2023 high
Renowned Federal Judge, 96, Faces Yearlong Suspension For Refusing to Retire

ICU Medical (ICUI) Stock Forecast, Price & News

$116.90
-4.30 (-3.55%)
(As of 09/21/2023 ET)
Compare
Today's Range
$116.88
$120.50
50-Day Range
$116.90
$180.72
52-Week Range
$116.88
$212.43
Volume
115,720 shs
Average Volume
180,237 shs
Market Capitalization
$2.82 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$216.00

ICU Medical MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
84.8% Upside
$216.00 Price Target
Short Interest
Bearish
5.74% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$6.28 M Sold Last Quarter
Proj. Earnings Growth
11.39%
From $5.18 to $5.77 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

292nd out of 965 stocks

Surgical & Medical Instruments Industry

40th out of 96 stocks


ICUI stock logo

About ICU Medical (NASDAQ:ICUI) Stock

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.

ICUI Price History

ICUI Stock News Headlines

The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
ICU Medical (NASDAQ:ICUI) Hits New 52-Week Low After Insider Selling
The "Plug and Play" Model Putting Online Giants to Shame
While e-commerce has been undergoing a turbulent time, a "simple" model has grown 4X faster than Amazon over the last 3 years. Applying this model to high-margin, recession-resistant businesses has shown to be profitable. But that's just the beginning of explaining the 400+% growth - and potential - of this "diamond in the rough."
ICU Medical: Continued Disappointments
ICU Medical Q2 Earnings Summary
ICU Medical (ICUI) Beats Q2 Earnings Estimates
The Medical Care That Helps No One
Q1 2023 ICU Medical Inc Earnings Call
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

ICUI Company Calendar

Last Earnings
8/07/2023
Today
9/22/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Forecast
$216.00
High Stock Price Forecast
$216.00
Low Stock Price Forecast
$216.00
Forecasted Upside/Downside
+84.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-3.44%

Debt

Sales & Book Value

Annual Sales
$2.28 billion
Cash Flow
$15.55 per share
Book Value
$87.15 per share

Miscellaneous

Free Float
22,293,000
Market Cap
$2.82 billion
Optionable
Optionable
Beta
0.64

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Mr. Vivek  JainMr. Vivek Jain (Age 51)
    CEO & Chairman
    Comp: $1.16M
  • Mr. Brian Michael Bonnell (Age 49)
    CFO & Treasurer
    Comp: $618.92k
  • Mr. Christian B. Voigtlander (Age 54)
    Chief Operating Officer
    Comp: $651.42k
  • Ms. Virginia Ruth SanzoneMs. Virginia Ruth Sanzone (Age 48)
    Corp. VP, Gen. Counsel, Sec. & Compliance Officer
    Comp: $552.73k
  • Clay Fradd
    Corp. VP of HR













ICUI Stock - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ICUI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ICUI, but not buy additional shares or sell existing shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price forecast for 2023?

1 Wall Street research analysts have issued 1-year price objectives for ICU Medical's stock. Their ICUI share price forecasts range from $216.00 to $216.00. On average, they predict the company's stock price to reach $216.00 in the next year. This suggests a possible upside of 84.8% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2023?

ICU Medical's stock was trading at $157.48 at the start of the year. Since then, ICUI stock has decreased by 25.8% and is now trading at $116.90.
View the best growth stocks for 2023 here
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our ICUI earnings forecast
.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) posted its quarterly earnings data on Monday, August, 7th. The medical instruments supplier reported $1.58 EPS for the quarter, topping the consensus estimate of $1.15 by $0.43. The medical instruments supplier had revenue of $549.31 million for the quarter, compared to analyst estimates of $562.90 million. ICU Medical had a negative net margin of 2.11% and a positive trailing twelve-month return on equity of 6.93%.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), Fidelity Disruptive Medicine ETF (FMED) and Principal Healthcare Innovators ETF (BTEC) and

What guidance has ICU Medical issued on next quarter's earnings?

ICU Medical updated its FY23 earnings guidance on Tuesday, August, 8th. The company provided EPS guidance of $6.00-6.85 for the period, compared to the consensus earnings per share estimate of $6.70.

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton, Dickinson and Company (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (7.12%), JPMorgan Chase & Co. (3.00%), Victory Capital Management Inc. (2.66%), State Street Corp (2.52%), Segall Bryant & Hamill LLC (1.54%) and Allspring Global Investments Holdings LLC (1.34%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $116.90.

How much money does ICU Medical make?

ICU Medical (NASDAQ:ICUI) has a market capitalization of $2.82 billion and generates $2.28 billion in revenue each year. The medical instruments supplier earns $-74,290,000.00 in net income (profit) each year or ($2.02) on an earnings per share basis.

How many employees does ICU Medical have?

The company employs 14,500 workers across the globe.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The official website for the company is www.icumed.com. The medical instruments supplier can be reached via phone at (949) 366-2183, via email at ir@icumed.com, or via fax at 949-366-8368.

This page (NASDAQ:ICUI) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -